Columbia, MO, United States of America

Jagannadhachari Kandala

This inventor holds 3 USPTO granted patents. Top assignees: Ramareddy Venkata Guntaka, Other. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jagannadhachari Kandala. Retrieved from https://idiyas.com/inventor/jagannadhachari-kandala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jagannadhachari Kandala: Innovator in Collagen Gene Research

Introduction

Jagannadhachari Kandala is a notable inventor based in Columbia, MO (US), recognized for his contributions to the field of molecular biology, particularly in the area of collagen gene expression. With a total of three patents to his name, Kandala's work has significant implications for understanding and potentially treating conditions related to collagen production.

Latest Patents

Kandala's latest patents focus on oligomers that inhibit the expression of collagen genes. These oligomers are designed to form a transcription-inhibiting complex when introduced into a cell, targeting the collagen-gene promoter region. Specifically, the oligomers, which are preferably phosphorothioate deoxyoligonucleotides or ribonucleotides, bind in an antiparallel orientation to the polypurine strand of the polypurine-polypyrimidine region of the mammalian .alpha.1(I) collagen gene promoter. This innovative approach holds promise for advancing therapeutic strategies in collagen-related disorders.

Career Highlights

Throughout his career, Kandala has made significant strides in the field of genetic research. His innovative work on oligomers has positioned him as a key figure in the exploration of gene expression regulation. His patents reflect a deep understanding of molecular mechanisms and their potential applications in medicine.

Collaborations

Kand

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…